CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests
Top Cited Papers
Open Access
- 1 April 2018
- journal article
- review article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 56 (4)
- https://doi.org/10.1128/jcm.01934-17
Abstract
Effective evaluations of antimicrobial susceptibility tests (ASTs) require robust study design. The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing has recognized that many published studies reporting the performance of commercial ASTs (cASTs) suffer from major design and/or analysis flaws, rendering the results difficult or impossible to interpret. This minireview outlines the current consensus of the Methods Development and Standardization Working Group of the CLSI Subcommittee on Antimicrobial Susceptibility Testing regarding best practices for systematic evaluation of the performance of an AST, including the analysis and presentation of essential data intended for publication.Keywords
This publication has 12 references indexed in Scilit:
- Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?Clinical Infectious Diseases, 2017
- Multicenter Evaluation of a Modified Cefoxitin Disk Diffusion Method and PBP2a Testing To Predict mecA -Mediated Oxacillin Resistance in Atypical Staphylococcus aureusJournal of Clinical Microbiology, 2017
- Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition BreakpointsJournal of Clinical Microbiology, 2017
- Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant EnterobacteriaceaeJournal of Clinical Microbiology, 2016
- Determination of disk diffusion susceptibility testing interpretive criteria using model-based analysis: development and implementationDiagnostic Microbiology and Infectious Disease, 2016
- Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI BreakpointsJournal of Clinical Microbiology, 2015
- Precision of Vancomycin and Daptomycin MICs for Methicillin-Resistant Staphylococcus aureus and Effect of Subculture and StorageJournal of Clinical Microbiology, 2014
- Colistin MIC Variability by Method for Contemporary Clinical Isolates of Multidrug-Resistant Gram-Negative BacilliJournal of Clinical Microbiology, 2013
- Modification of the error-rate bounded classification scheme for use with two MIC break pointsDiagnostic Microbiology and Infectious Disease, 1992
- Susceptibility Tests of Anaerobic Bacteria: Statistical and Clinical ConsiderationsThe Journal of Infectious Diseases, 1974